Fumihiko Kinoshita

11PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCell physiologyDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 23, 2026
Thymic carcinoma, initially unresectable, converted to complete resection with pathological complete response following chemotherapy alone.

|Apr 03, 2026
Surgical resection of an adrenocorticotropic hormone-producing pulmonary typical carcinoid with mediastinal lymph node metastasis and high programmed death-ligand 1 expression.

Masakazu Matsuda, Fumihiko Kinoshita, Yukina Takeichi

|Dec 01, 2025
Identifying Key Variances in Clinical Pathways Associated With Prolonged Hospital Stays Using Machine Learning and ePath Real-World Data: Model Development and Validation Study.

Saori Tou, Koutarou Matsumoto, Asato Hashinokuchi

|Apr 18, 2025
Data-driven prediction of prolonged air leak after video-assisted thoracoscopic surgery for lung cancer: Development and validation of machine-learning-based models using real-world data through the ePath system.

Saori Tou, Koutarou Matsumoto, Asato Hashinokuchi

|Mar 17, 2025
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study.

Fumihiko Kinoshita, Shigeru Tanzawa, Toshihiro Misumi

|Feb 17, 2025
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.

Shigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi

Pageof 2

Frequent Collaborators

2 joint publications

Takanori Yamashita

2 joint publications

Mototsugu Shimokawa

2 joint publications

Tomoyoshi Takenaka

2 joint publications

Koutarou Matsumoto